CD9 Is a Novel Target in Glomerular Diseases Typified by Parietal Epithelial Cell Activation

2020 ◽  
Vol 75 (5) ◽  
pp. 812-814
Author(s):  
Bart Smeets ◽  
Laura Miesen ◽  
Stuart J. Shankland
2015 ◽  
Vol 2015 ◽  
pp. 1-8 ◽  
Author(s):  
Hua Su ◽  
Shan Chen ◽  
Fang-Fang He ◽  
Yu-Mei Wang ◽  
Philip Bondzie ◽  
...  

The glomerular parietal epithelial cells (PECs) have aroused an increasing attention recently. The proliferation of PECs is the main feature of crescentic glomerulonephritis; besides that, in the past decade, PEC activation has been identified in several types of noninflammatory glomerulonephropathies, such as focal segmental glomerulosclerosis, diabetic glomerulopathy, and membranous nephropathy. The pathogenesis of PEC activation is poorly understood; however, a few studies delicately elucidate the potential mechanisms and signaling pathways implicated in these processes. In this review we will focus on the latest observations and concepts about PEC activation in glomerular diseases and the newest identified signaling pathways in PEC activation.


Author(s):  
Jennifer Eymael ◽  
Laura Miesen ◽  
Fieke Mooren ◽  
Jitske Jansen ◽  
Jack Wetzels ◽  
...  

2013 ◽  
Vol 83 (6) ◽  
pp. 988-990 ◽  
Author(s):  
Mariya T. Sweetwyne ◽  
Katalin Susztak

2013 ◽  
Vol 183 (6) ◽  
pp. 1769-1778 ◽  
Author(s):  
Paola Rizzo ◽  
Norberto Perico ◽  
Elena Gagliardini ◽  
Rubina Novelli ◽  
Malcolm R. Alison ◽  
...  

2012 ◽  
Vol 7 (11) ◽  
pp. 1852-1858 ◽  
Author(s):  
Huma Fatima ◽  
Marcus J. Moeller ◽  
Bart Smeets ◽  
Hai-Chun Yang ◽  
Vivette D. D’Agati ◽  
...  

2017 ◽  
Vol 28 (12) ◽  
pp. 3563-3578 ◽  
Author(s):  
Yosu Luque ◽  
Olivia Lenoir ◽  
Philippe Bonnin ◽  
Lise Hardy ◽  
Anna Chipont ◽  
...  

2014 ◽  
Vol 95 (3) ◽  
pp. 273-282 ◽  
Author(s):  
Alexander Holderied ◽  
Simone Romoli ◽  
Jonathan Eberhard ◽  
Lukas A Konrad ◽  
Satish K Devarapu ◽  
...  

2017 ◽  
Vol 187 (11) ◽  
pp. 2441-2450 ◽  
Author(s):  
Paola Rizzo ◽  
Rubina Novelli ◽  
Cinzia Rota ◽  
Elena Gagliardini ◽  
Barbara Ruggiero ◽  
...  

Author(s):  
Benjamin J. Moss ◽  
Stefan W. Ryter ◽  
Ivan O. Rosas

The pathogenesis of idiopathic pulmonary fibrosis (IPF) involves a complex interplay of cell types and signaling pathways. Recurrent alveolar epithelial cell (AEC) injury may occur in the context of predisposing factors (e.g., genetic, environmental, epigenetic, immunologic, and gerontologic), leading to metabolic dysfunction, senescence, aberrant epithelial cell activation, and dysregulated epithelial repair. The dysregulated epithelial cell interacts with mesenchymal, immune, and endothelial cells via multiple signaling mechanisms to trigger fibroblast and myofibroblast activation. Recent single-cell RNA sequencing studies of IPF lungs support the epithelial injury model. These studies have uncovered a novel type of AEC with characteristics of an aberrant basal cell, which may disrupt normal epithelial repair and propagate a profibrotic phenotype. Here, we review the pathogenesis of IPF in the context of novel bioinformatics tools as strategies to discover pathways of disease, cell-specific mechanisms, and cell-cell interactions that propagate the profibrotic niche. Expected final online publication date for the Annual Review of Pathology: Mechanisms of Disease, Volume 17 is January 2022. Please see http://www.annualreviews.org/page/journal/pubdates for revised estimates.


Sign in / Sign up

Export Citation Format

Share Document